Katsara, M

< Back to all Authors
Group by: Item type | Date
Number of items: 8.

August 2008

Katsara, M, Yuriev, E, Ramsland, PA, Deraos, G, Tselios, T, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2008) Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2. Molecular Immunology, 45 (13). 3661 - 3670. ISSN 0161-5890

November 2011

Laimou, D, Lazoura, E, Troganis, AN, Matsoukas, MT, Deraos, SN, Katsara, M, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Tselios, T (2011) Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling. Journal of Computer - Aided Molecular Design, 25 (11). 1019 - 1032. ISSN 0920-654X

May 2012

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Katsara, M, Day, S, Tselios, T and Matsoukas, J (2012) Immunotherapeutic aspects for MS: are we heading in the right direction? In: Progress in MS Research Conference 2011, 26 October 2011-28 October 2011, Melbourne, Australia.

2014

Katsara, M, Deraos, S, Tselios, T, Pietersz, Geoff, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2014) Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Immunotherapy, 6 (6). 709 - 724. ISSN 1750-743X

7 July 2017

Dargahi, Narges, Katsara, M, Tselios, T, Androutsou, ME, de Courten, Maximilian ORCID: 0000-0001-9997-9359, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2017) Multiple sclerosis: Immunopathology and treatment update. Brain Sciences, 7 (7). ISSN 2076-3425

1 March 2018

Katsara, M and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2018) Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics. Medicinal Chemistry, 14 (2). 104 - 105. ISSN 1573-4064

15 May 2018

Lourbopoulos, A, Matsoukas, MT, Katsara, M, Deraos, G, Giannakopoulou, A, Lagoudaki, R, Grigoriadis, N, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2018) Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 26 (9). 2221 - 2228. ISSN 0968-0896

20 October 2020

Florou, Despoina, Katsara, M, Feehan, Jack ORCID: 0000-0002-9627-1299, Dardiotis, Efthimios and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2020) Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab. Brain Sciences, 10 (10). ISSN 2076-3425